Howard Marks's INDV Position
Indivior Pharmaceuticals Inc — 8 quarters of data (Q1 2024 to Q4 2025)
Current Shares
7.11M
Current Value
$255.06M
Peak Shares
257.79M
Q3 2025
Overall Change
+112%
Shares Over Time
Q1 2024
3.35M
Q2 2024
4.49M
+34%
Q3 2024
9.52M
+112%
Q4 2024
8.73M
-8%
Q1 2025
11.01M
+26%
Q2 2025
11.01M
0%
Q3 2025
257.79M
+2242%
Q4 2025
7.11M
-97%
Quarterly Detail
| Quarter | Shares | Value | $/Share | Change | Shares Δ |
|---|---|---|---|---|---|
| Q4 2025 2026-02-17 | 7.11M | $255.06M | $35.88 | -97% | -250,676,754 |
| Q3 2025 2025-11-13 | 257.79M | $10.69M | $0.04 | +2242% | +246.78M |
| Q2 2025 2025-08-13 | 11.01M | $162.28M | $14.74 | 0% | 0 |
| Q1 2025 2025-05-15 | 11.01M | $103.45M | $9.40 | +26% | +2.28M |
| Q4 2024 2025-02-12 | 8.73M | $112.00B | $12824.58 | -8% | -788,432 |
| Q3 2024 2024-11-14 | 9.52M | $94.07B | $9879.04 | +112% | +5.03M |
| Q2 2024 2024-08-14 | 4.49M | $70.43B | $15674.84 | +34% | +1.14M |
| Q1 2024 2024-05-14 | 3.35M | $71.71B | $21399.46 | New | - |